During the past decade, Signature Research Associates Inc conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Signature Research Associates Inc" are "Schizophrenia" (2 trials), "Bipolar 1 Disorder" (1 trials), "Major Depressive Disorder" (1 trials) and "Treatment Resistant Depression" (1 trials). Many other conditions were trialed in "Signature Research Associates Inc" in a lesser frequency.

Most popular intervention types in "Signature Research Associates Inc" are "Combination Product" (2 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abilify MyCite - Digital Medicine System" (1 trials), "Abilify MyCite®" (1 trials), "Aripiprazole or other oral antipsychotics" (1 trials) and "Vagus Nerve Stimulation (VNS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Signature Research Associates Inc" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Signature Research Associates Inc". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Signature Research Associates Inc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Signature Research Associates Inc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".